Potassium Carbonate → 2(R)-(3-chloro-4-methanesulfonyl-phenyl)-3-cyclopentyl-N-[5-(2(S),3-dihydroxy-propyl)-pyrazin-2-yl]-propionamide

HRID 720010노트

반응식

HRID 720010 반응식
[C:1](=[O:4])([O-])[O-].[K+].[K+].[CH2:7]([C:10]1[N:11]=[CH:12][C:13]([NH:16][C:17](=[O:36])[C@@H:18]([C:25]2[CH:30]=[CH:29][C:28]([S:31]([CH3:34])(=[O:33])=[O:32])=[C:27]([Cl:35])[CH:26]=2)[CH2:19][CH:20]2[CH2:24][CH2:23][CH2:22][CH2:21]2)=[N:14][CH:15]=1)C=C.S(S([O-])=O)([O-])(=O)=O.[Na+].[Na+].[C:46]([OH:50])(C)(C)C.O>C(OCC)(=O)C.[Cl-].[Na+].O.[Fe-3](C#N)(C#N)(C#N)(C#N)(C#N)C#N.[K+].[K+].[K+].[Os](=O)(=O)(=O)=O.CC[C@H]1[C@H]2C[C@H]([C@H](OC3C4C(=CC=CC=4)C(O[C@H](C4C=CN=C5C=4C=C(OC)C=C5)[C@@H]4N5C[C@H](CC)[C@@H](CC5)C4)=NN=3)C3C=CN=C4C=3C=C(OC)C=C4)N(CC2)C1.C1(C)C=CC=CC=1>[Cl:35][C:27]1[CH:26]=[C:25]([C@@H:18]([CH2:19][CH:20]2[CH2:24][CH2:23][CH2:22][CH2:21]2)[C:17]([NH:16][C:13]2[CH:12]=[N:11][C:10]([CH2:7][C@H:1]([OH:4])[CH2:46][OH:50])=[CH:15][N:14]=2)=[O:36])[CH:30]=[CH:29][C:28]=1[S:31]([CH3:34])(=[O:33])=[O:32]

참가 물질

12

반응물 4

HCID 11430Potassium CarbonateHCID 656671Sodium PyrosulfiteHCID 67482647N-(5-allyl-pyrazin-2-yl)-2(R)-(3-chloro-4-methanesulfonyl-phenyl)-3-cyclopentylpropionamideHCID 714019492-Methylpropan-2-ol--water (1/1)

생성물 1

HCID 104803772(R)-(3-chloro-4-methanesulfonyl-phenyl)-3-cyclopentyl-N-[5-(2(S),3-dihydroxy-propyl)-pyrazin-2-yl]-propionamide수율 77.1%

시약·촉매·용매 7

HCID 1140Toluene촉매HCID 30318Osmium Tetroxide촉매HCID 510036741-((1R)-((2R,4R,5S)-5-ethylquinuclidin-2-yl)(6-methoxyquinolin-4-yl)methoxy)-4-((1R)-((2R,4S,5R)-5-ethylquinuclidin-2-yl)(6-methoxyquinolin-4-yl)methoxy)phthalazine촉매HCID 178511488HCID 178511488, 화합물촉매HCID 962Water용매HCID 5234Sodium Chloride용매HCID 8857Ethyl Acetate용매

반응 조건

온도
0 °C

실험 절차

A yellow solution of potassium ferricyanide (1.00 g, 3.037 mmol), potassium carbonate (430.0 mg, 3.111 mmol), and (DHQ)2PHAL (19.0 mg, 0.0244 mmol) in tert-butyl alcohol/water (16.0 mL, 1:1) was cooled to 0° C. and then treated with a 0.2M solution of osmium tetroxide in toluene (0.048 mL, 0.0096 mmol) followed by the N-(5-allyl-pyrazin-2-yl)-2(R)-(3-chloro-4-methanesulfonyl-phenyl)-3-cyclopentylpropionamide (446.0 mg, 0.996 mmol). The reaction mixture was stirred at 0° C. for 4 h. The reaction mixture was then diluted with ethyl acetate and sodium metabisulfite (0.45 g, 2.37 mmol) and allowed to warm to 25° C. where it was stirred for 15 min. The mixture was then diluted with a saturated aqueous sodium chloride solution and water and extracted with ethyl acetate. The combined organic layers were dried over anhydrous sodium sulfate, filtered, and concentrated in vacuo. Biotage chromatography (FLASH 40M, Silica, 2/3 hexanes/ethyl acetate to ethyl acetate) afforded 2(R)-(3-chloro-4-methanesulfonyl-phenyl)-3-cyclopentyl-N-[5-(2(S),3-dihydroxy-propyl)-pyrazin-2-yl]-propionamide (370.2 mg, 77.1%) as a white foam: mp 61–65° C. (foam to gel); (ES)+-HRMS m/e calcd for C22H28ClN3O5S (M+H)+ 482.1511, found 482.1516.

후처리

  1. temperatureto warm to 25° C. where it
  2. stirringwas stirred for 15 min
  3. extractionextracted with ethyl acetate
  4. dry with materialThe combined organic layers were dried over anhydrous sodium sulfate
  5. filtrationfiltered
  6. concentrationconcentrated in vacuo

출처 및 근거

ORD 기록
ord-c0d19ccf414043939db52726d227956a
출처 데이터셋
uspto-grants-2006_11
특허 번호
US07132425B2

반응 노트

불러오는 중…